Bolivia vs Ecuador: Average cost of drugs for extensively drug-resistant tuberculosis

Bolivia

753 constant 2022 US$

in 2024

Ecuador

451 constant 2022 US$

in 2024

Bolivia rank

48th

Ecuador rank

50th

Average cost of drugs for extensively drug-resistant tuberculosis over time

Bolivia currently reports 753 constant 2022 US$ against 451 constant 2022 US$ in Ecuador, a difference of 302 constant 2022 US$.

That makes Bolivia's figure about 1.7 times Ecuador's.

The two have swapped places 1 time across 5 shared years of data; in 2017 it was Ecuador ahead.

Bolivia ranks 48th and Ecuador ranks 50th of 56 countries.

Indicator: Average cost of drugs for extensively drug-resistant tuberculosis
Unit: constant 2022 US$
Source: WHO (2025) – with minor processing by Our World in Data
Licence: CC BY 4.0 (Our World in Data)
Coverage: 56 places, 394 data points, 2017–2024
Last refreshed: 07 August 2026

Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.